Skip to main content

Smart stability indicating spectrophotometric methods for determination of modafinil: the promising treatment for post-covid neurological syndrome


Modafinil (MDF) is one of the neurostimulants with a potential effect in the COVID-19 ICU ventilated patients and post-COVID neurological syndrome treatment. Four rapid, simple and cost-effective stability indicating spectrophotometric methods were used for estimation of MDF in the presence of its acidic degradation product, namely; ratio difference (RD), first derivative of the ratio spectra (1DD), mean centering (MCR) and ratio subtraction method (RS). These methods were validated according to ICH guidelines and all methods revealed a good linearity in concentration range of (5-30 µg/mL) in addition to a good accuracy and precision with mean percentage recovery of 99.97 ± 0.305 for (RD), 100.10 ± 0.560 for (1DD), 100.02 ± 0.483 for (MCR) & 99.18 ± 1.145 for (RS) method. Specificity of the proposed methods was assessed and MDF was determined in the presence of up to 80% of its acidic degradation product for RD, 1DD, MCR and RS methods. The proposed methods were successfully applied for the determination of MDF in bulk powder and its tablet dosage form with mean percentage recovery of 100.33 ± 0.915 for (RD), 100.62 ± 0.985 for (1DD), 99.70 ± 0.379 for (MCR) and 100.21 ± 0.313 for (RS) method. The results obtained were statistically compared with those of official HPLC method and showed no significant difference with relevance accuracy and precision.

Peer Review reports


Modafinil is 2- (benzhydryl sulfinyl) acetamide (Fig. 1) [1]. used as wakefulness promoting agent for its anti-oxidative and neuroprotective influences with unknown mechanism till now and it still controversial, it can be taken concomitantly with flecainide to treat narcolepsy [2], some clinical trials proof that MDF may relieve fatigue and neurobehavioral dysfunction in primary brain tumors patients [3].

Fig. 1
figure 1

Chemical structure of Modafinil

COVID-19 patients who are mechanically ventilated may require greater doses of opioids and sedatives to avoid self-extubation and reduce ventilator-induced lung damage. MDF safety profile as well as its effect when administered to those hypoactive and lethargic critically patients make it an optimum choice in ventilated COVID-19 patients. MDF importance comes from its ability to avoiding tracheostomy. According to a recent literature study, tracheostomy patient with COVID-19 was completely extubated after receiving modafinil [4, 5].

Various analytical methods have been reported to estimate MDF individually and in concomitant with other drug in fluids or pharmaceutical dosage form using direct spectrophotometric method (Zero order) at 252 nm, first order derivative method at 234 nm [6], Direct spectrophotometric method at 260 nm [7], Colorimetric method using methyl orange at 525 nm and methylene blue at 664 nm [8], Colorimetric method utilizing 2,4-dinitrophenol and 1,2-naphthoquinone-4-sulphonate at wavelengths of 475 nm and 430 nm respectively [9], RP- HPLC [10, 11], capillary electrophoresis [12] and LC/MS [13] but few of them have been developed to estimate MDF in the presence of its degradation products using HPLC [14, 15], HPTLC [16] and capillary zone electrophoresis [17].

The stability of MDF was studied in few papers [14,15,16,17,18]. No spectrophotometric methods have been reported for the determination of MDF in the presence of its degradation product. So the purpose of this study is to develop simple, time saving, economic, precise and accurate stability-indicating spectrophotometric methods for determination of MDF in the presence of its degradation products.


Apparatus and software

Shimadzu 1800 UVPC spectrophotometer using 1.00 cm quartz cells (Shimadzu, Kyoto, Japan). JENWAY hot plate, JENWAY 3510 pH meter (Stone, Staffs, UK), and MATLAB® software.

Materials and reagents

Pure sample

Modafinil was kindly supplied by Mash Premiere Pharmaceutical Industries (Cairo, Egypt); its purity was found to be 100.03 ± 0.598 according to the official method [1].

Pharmaceutical dosage form

BRAVAMAX® tablets, Batch No. 181142A and labeled to contain 200 mg/tab., manufactured by Chemipharm Pharmaceutical Industries (6th October, Egypt) were purchased from local market.

Degraded sample

Degradation product was prepared by refluxing 25 mg of modafinil powder with 5 N methanolic HCl for 12 h. at 80 °C, then the solution was neutralized with KOH, followed by purification to obtain pure powder of the degradation product which was checked by thin layer chromatography. as detailed in our previous work [18].

Chemicals and reagents

All chemicals used throughout this study were of analytical grade, Methanol (Merck, Germany), Distilled water prepared-in house by Aquatron water still A8000 system, Hydrochloric acid 37% (Honeywell, USA), and Potassium Hydroxide (El NASR Pharmaceutical Chemicals Co., Abu-Zabaal, Cairo, Egypt).


Stock standard solution

Stock standard solutions of MDF and its degradation product (1 mg/mL) were prepared in methanol.

Working standard solutions

Working standard solutions of MDF and its degradation products (100 µg/mL) were prepared from their corresponding stock standard solutions in methanol.


Construction of calibration curves

Aliquots equivalent to 50–300 μg of MDF were accurately transferred from their working standard solutions into a set of 10 mL volumetric flasks and the volumes were completed using methanol then Zero order absorption spectra were scanned at (200–400 nm) and stored in the computer.

Ratio difference method (RD)

Ratio spectra were obtained by dividing the stored zero order absorption spectra of (5–30 µg/mL) MDF by the spectrum of its acidic degradation product (70 µg/mL) and stored in computer. The difference in the amplitudes between 224.4 nm and 232.8 nm was measured, Calibration graph was constructed and the linear regression equation between the difference in amplitude and concentration was computed for the determination of MDF.

First derivative of the ratio spectra (1DD)

The first derivative of the stored ratio spectra of MDF (5–30 µg/mL) were obtained using scaling factor 10 and Δλ = 4. The peak amplitude of the obtained spectra was measured at 241.8 nm. Calibration graph was plotted between peak amplitude and concentration, and then regression equation was calculated.

Mean centering (MCR)

The mean centering of the stored ratio spectra of MDF (5–30 µg/mL) were obtained using MATLAB® software and calibration graph of the mean centered values at 224 nm was constructed against their corresponding concentrations and regression equation was calculated.

Ratio subtraction method (RS)

Ratio subtraction method was manipulated, and the stored zero order absorption spectra of MDF (5–30 µg/mL) manipulated to its second derivative spectra, calibration curve was constructed by plotting absorbance at 223.7 nm of second derivative spectra of MDF against the corresponding concentration and then linear regression equation was calculated.

Analysis of laboratory prepared mixtures

Laboratory prepared mixtures containing different percentages (20–80%) of the degradation product were analyzed. The procedures under construction of calibration curves for RD, 1DD and MCR were followed. Ratio subtraction method was realized via working on laboratory prepared mixtures and four steps were applied. The first step was performed by dividing synthetic lab mixtures on suitable divisor (70 µg/mL of the acidic degradation product); the second step was subtracting the constant value (plateau region) from the obtained ratio spectra. The third step was multiplying the obtained spectra by the spectrum of the divisor to obtain the original spectra of MDF, and the final step was manipulating the spectra of the previous step to obtain second derivative spectra. MDF concentrations were calculated from the regression equation of each method.

Application of pharmaceutical dosage preparation

Ten tablets of BRAVAMAX® were weighed and grinded well, a portion of the powder equivalent to 50 mg MDF was weighed and transferred to 50-mL volumetric flask, 30 mL of methanol was added and sonicated for 25 min and the solution was filtrated into another 50-mL volumetric flask. The volume completed to the mark with the same solvent to prepare stock tablet solution equivalent to (1 mg/mL) MDF. Ten milliliters from (1 mg/mL) MDF transferred into 100 mL volumetric flask using the same solvent to complete volume to get working solution of (100 µg/mL). Then the procedures completed as detailed under each method.

Results and discussion

Stability testing assesses for pharmaceutical products to ensure their safety and effectiveness through subjecting them to normal and accelerated conditions which help in the determination of shelf life, storage condition, ensure quality and suitable packaging material before supplying to market [19].

In our previous work degradation of MDF was studied via series of trials with different degradation conditions until prove its liability to acid and base. In addition to confirming that no oxidative degradation was observed upon using different oxidative degradation conditions. Structure elucidation was performed using IR & mass spectrometry then degradation pathway was predicted[18].

Spectrophotometry is an economical and simple method in comparison with HPLC method besides its availability in all quality control laboratories. The main problem facing the analysts is the overlapping spectra of the drug and its degradation products. Manipulating ratio spectra was the excellent solution to face this obstacle [20].

RD method

Absorption spectra of MDF and its degradation product show severe overlap (Fig. 2), which hinders the determination of MDF using direct spectrophotometric method. In addition, classical derivative spectrophotometric method failed in determination of MDF. So, we resorted to different spectrophotometric methods manipulating ratio spectra.

Fig. 2
figure 2

Zero order absorption spectra of (10 µg/mL) modafinil (–) and (70 µg/mL) of its acidic degradation (-—-) in methanol

Simplicity, accuracy and reproducibility are the most remarkable features of ratio difference method [21, 22], which involves two main requirements [23], the first one is the divisor selection which successfully chosen to be 70 µg/mL of the acidic degradation product that was showing minimal noise. The second requirement is the selection of two wavelengths which found to be λ1 (224.4 nm) and λ2 (232.8 nm) (Fig. 3). A calibration curve was constructed representing the relationship between the ΔP of the selected wavelengths and the corresponding concentrations. Good linearity, maximum sensitivity with a satisfactory recovery in the range of (5–30 µg/mL) of the drug were obtained as listed in (Table 1). MDF could be determined in the presence of up to 70% of its degradation product.

Fig. 3
figure 3

Ratio spectra of modafinil 5-30 µg/mL(–) and 50 µg/mL of its acidic degradation product (-—-) using 70 µg/mL of degradation as a divisor in methanol

Table 1 Assay validation sheet of the proposed methods for the determination of pure samples of modafinil

1DD method

First derivative of the ratio spectra method is one of the simplest spectrophotometric method [21, 22]. 1DD easily applicable for the quantitative analysis of MDF in the presence of its acidic degradation despite of the overlapping spectra of them. It involves the conversion of zero order spectra to ratio spectra using (70 µg/mL) of MDF acidic degradation product as divisor, then first derivative spectra were obtained using scaling factor 10 and Δλ = 4 nm as in (Fig. 4). Calibration curve was constructed representing the relationship between peak amplitude at 241.8 nm and the corresponding concentrations. Regression equation was calculated in the range of (5–30 µg/mL) as listed in (Table 1). MDF could be determined in the presence of up to 80% of its degradation product.

Fig. 4
figure 4

First derivative of ratio spectra of 5-30 µg/mL modafinil (–) and 50 µg/mL of degradation product () using 70 µg/mL of degradation as a divisor at (241.8 nm) in methanol

Mean centering

Calibration graph was constructed in the range of MDF of (5–30 µg/mL) for the values of the mean centered spectra at 224 nm, after transferring the ratio spectra to MATLAB® for subsequent manipulation. As this method based on mean centering of ratio spectra rather than the derivative steps, therefore signal-to-noise ratio is enhanced [22, 24, 25] (Fig. 5). Regression equation was computed (Table1). MDF could be determined in the presence of up to 80% of its degradation product.

Fig. 5
figure 5

Mean centering of ratio spectra of MDF 5-30 µg/mL using the spectrum of 70 µg/mL of degradation as a divisor at 226 nm in methanol

Ratio subtraction method

Ratio subtraction method [21, 26] is implied as degradation product spectrum is more extended than the absorption spectrum of MDF (Fig. 2). This method was achieved through dividing laboratory prepared mixtures by a carefully chosen divisor 70 µg/mL acid degradation thus leading to a straight line parallel to zero line at range 275 nm- 333 nm referring to constant (Fig. 6A). After that subtracting this constant from the obtained spectra (Fig. 6B). The obtained spectrum was then multiplied by the divisor spectrum (Fig. 6C). Finally, the original spectrum of MDF was obtained and manipulated to its second derivative spectrum, MDF can be determined at 223.7 nm (Fig. 6D). It was difficult to construct the calibration curve from zero order spectra because of two main reasons; first, MDF main peak was showed in zero spectra at range (204-211 nm), while the second reason was the peak shifting in this range as the concentration increased. A first derivative spectrum was also hindered to be constructed because of the peak shifting. The linear correlation was constructed in the range of (5–30 µg/mL) (Table 1). MDF could be determined in the presence of up to 80% of its degradation product.

Fig. 6
figure 6

A Ratio spectra of laboratory prepared mixtures of modafinil and its degradation product using 70 µg/mL of its degradation product as a divisor. B The obtained ratio spectra after subtraction of the constant. C The obtained spectra of modafinil after multiplication by the divisor. D Second derivative of the obtained spectra of the laboratory prepared mixtures

Method validation

ICH guidelines for method validation [27] were followed for all the proposed methods. Results of accuracy, precision, and repeatability are presented in (Table 1). Robustness was realized by determining the sample under small wavelength variation about ± 2 nm from the specified wavelength as shown in (Table 1).

Application of the proposed methods in assay of laboratory prepared mixtures

Specificity of the proposed methods was assessed by the analysis of different laboratory prepared mixtures containing different percentages (20–80%) of MDF standard solution and the degradation product. The recovery percentage and RSD% were acceptable enough to assess the specificity as shown in (Table 2) [28].

Table 2 Determination of modafinil in laboratory-prepared mixtures by the proposed spectrophotometric methods

Application of the proposed methods in assay of pharmaceutical formulation

The suggested methods were effectively used for the analysis of MDF in Bravamax® tablets and the validity of the methods was further assessed by applying standard addition technique (Table 3).

Table 3 Quantitative determination of modafinil in Bravamax® tablet by the suggested methods and results of application of standard addition technique

No considerable difference was observed in the statistical comparison between the results obtained from the proposed methods of the pure drug samples and those results from the official method [1] (Table 4)

Table 4 Statistical analysis of the results obtained by the proposed methods and the reported method for the determination of modafinil in pure powder form


Main reason for currently underway studies on modafinil in the last 3 years is to prioritize its effectiveness in the post neurological syndrome caused by global epidemic [COVID-19]. Four simple, accurate and time-saving stability indicating spectrophotometric methods were developed for quantitative estimation of MDF in the presence of its degradation products. First derivative of the ratio spectra, MCR and RS methods resolve the challenging interference of MDF spectra in the presence of 80% of its degradation products. To the best of our knowledge no spectrophotometric methods has been published for estimation of MDF in a presence of its degradation products.

Taking into consideration, the easiest manipulation of RD method (a one-step process). that achieves good accuracy and high reproducibility While 1DD and MCR both are two-step methods but MCR provides enhanced signal-to-noise ratio as it is based on mean centering of ratio spectra rather than the derivative steps which enhance the selectivity. Ratio subtraction method has the advantage of restoring the original spectra of proposed drug despite being limited for analyzing binary mixtures where the spectrum of one component must extend over the other. Therefore, Application of the suggested methods convenient to MDF quality control routine analysis, because of their simplicity and validity according to ICH guideline.

Availability of data and materials

Spectrophotometric data obtained from spectrophotometer software. Datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.





Ratio difference


First derivative of the ratio spectra


Mean centering


Ratio subtraction method


High performance liquid chromatography


Reversed phase High performance liquid chromatography


Liquid chromatography—mass spectrometry


High performance thin—layer chromatography


Infrared spectrophotometer


Ultra-performance liquid chromatography mass spectrophotometer









ICH guidelines:

International council on harmonization


Standard deviation


Relative standard deviation


Quality control


Intensive care unit


  1. BP. British Pharmacopoeia, The Stationary Office, London, 2013.

  2. Duchêne A, Perier M, Zhao Y, Liu X, Thomasson J, Chauveau F, Piérard C, Lagarde D, Picoli C, Jeanson T. Impact of astroglial connexins on modafinil pharmacological properties. Sleep. 2016;39(6):1283–92.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kaleita T, Wellisch D, Graham C, Steh B, Nghiemphu P, Ford J, Lai A, Peak S, Cloughesy T. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. J Clin Oncol. 2006;24(18 suppl):1503–1503.

    Article  Google Scholar 

  4. Roy D, Song J, Awad N, Zamudio P. Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19. BMJ Case Rep. 2021;14(3): e239781.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Amer M, Bawazeer M, Butt AS, Dahhan TI, Kseibi E, Jamil MG. Modafinil for Wakefulness in the critical care units: a literature review and case series including COVID-19 patients at a tertiary care saudi hospital. medRxiv. 2021.

    Article  Google Scholar 

  6. Basniwal PK, Jain D. Determination of modafinil in tablet formulation using three new validated spectrophotometric methods. Malays J Anal Sci. 2014;18(2):329–36.

    Google Scholar 

  7. Bijithra C, Ragan G, Shanmugasundaram P. Analytical method development and validation of modafinil in pure and tablet dosage form by UV spectroscopy. Res J Pharm Technol. 2016;9(8):1303.

    Article  Google Scholar 

  8. Seshamamba BS, Satyanarayana PV, Sekaran CB. Use of brominating agent for the spectrophotometric determination of narcoleptic drug. Modafinil Jordan J Chem. 2014;9(3):187–98.

    Article  CAS  Google Scholar 

  9. Seshamamba BS, Satyanarayana PV, Sekharan C. Simple spectrophotometric methods for quantification of modafinil using 1, 2-naphthoquinone-4-sulphonate and 2, 4-dinitrophenol as analytical reagents. J Iran Chem Soc. 2014;2(4):255–68.

    Google Scholar 

  10. Schwertner HA, Kong SB. Determination of modafinil in plasma and urine by reversed phase high-performance liquid-chromatography. J Pharm Biomed Anal. 2005;37(3):475–9.

    Article  CAS  PubMed  Google Scholar 

  11. Younus M, Arif MF, Richards MP, Kumar B. Determination of venlafaxine and modafinil in individual tablet dosage forms using single RP-HPLC method. Trop J Pharm Res. 2013;12(2):239–45.

    Article  CAS  Google Scholar 

  12. Azzam KMA, Saad B, Adnan R, Saleh MI. Enantioselective determination of modafinil in pharmaceutical formulations by capillary electrophoresis, and computational calculation of their inclusion complexes. Microchim Acta. 2009;166(3–4):311–7.

    Article  CAS  Google Scholar 

  13. McKinney AR, Suann CJ, Stenhouse AM. The detection of modafinil and its major metabolite in equine urine by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2005;19(10):1217–20.

    Article  CAS  PubMed  Google Scholar 

  14. Khan AA, Panda SK, Sahoo SK, Dash AK. Stability indicating RP-HPLC method for determination of modafinil in bulk & its formulations. Int J Biol Pharm Res. 2011;2(1):39–44.

    Google Scholar 

  15. Vilas C, Milind U. A validated stability indicating HPLC assay method for modafinil hydrochloride in bulk drug. Int J Pharm Chem Sci. 2013;2:207–13.

    Google Scholar 

  16. Pandya GP, Joshi HS. Stability indicating HPTLC method for estimation of modafinil in the bulk and tablet formulation. IOSR J Pharm Biol Sci. 2013;5:22–8.

    Article  Google Scholar 

  17. Azzam KMAl, Saad B, Aboul-Enein HY, Elbashir AA. Assay and stability-indicating capillary zone electrophoretic method for the determination of modafinil in bulk and its pharmaceutical preparations. J Liq Chromatogr Relat Technol. 2009;33(2):167–78.

    Article  CAS  Google Scholar 

  18. Elsheikh SG, Hassan AM, Fayez YM, El-Mosallamy SS. Greenness assessment of two validated stability-indicating chromatographic methods for estimating modafinil using the analytical eco-scale. J AOAC Int. 2021.

    Article  Google Scholar 

  19. Huynh-Ba K. Handbook of stability testing in pharmaceutical development: regulations, methodologies, and best practices, New York. NewYork: Springer Science & Business Media; 2008.

    Google Scholar 

  20. Talsky G, Mayring L, Kreuzer H. High-Resolution, Higher-Order UV/VIS Derivative Spectrophotometry. Angew Chem Int Ed. 1978;17(11):785–99.

    Article  Google Scholar 

  21. Mostafa NM, Abdel-Fattah L, Weshahy SA, Hassan NY, Boltia SA. Validated stability-indicating spectrophotometric methods for the determination of cefixime trihydrate in the presence of its acid and alkali degradation products. J AOAC Int. 2015;98(1):35–45.

    Article  CAS  PubMed  Google Scholar 

  22. Mostafa NM, Fayez YM, Farid JF, Abd AEAB, El-Alim. Stability indicating spectrophotometric methods for determination of Ivabradine hydrochloride in the presence of its degradation product". Anal Chem Lett. 2017;7(2):280–94.

    Article  CAS  Google Scholar 

  23. Lotfy HM, Hassan NY, Elgizawy SM, Saleh SS. Comparative study of new spectrophotometric methods; an application on pharmaceutical binary mixture of ciprofloxacin hydrochloride and hydrocortisone. J Chil Chem Soc. 2013;58(3):1892–8.

    Article  CAS  Google Scholar 

  24. Tantawy MA, El-Ragehy NA, Hassan NY, Abdelkawy M. Stability-indicating spectrophotometric methods for determination of the anticoagulant drug apixaban in the presence of its hydrolytic degradation product. Spect Acta Mol Biomol Spectrosc. 2016;159:13–20.

    Article  CAS  Google Scholar 

  25. Merey HA, El-Mosallamy SS, Hassan NY, El-Zeany BA. Simultaneous determination of fluticasone propionate and azelastine hydrochloride in the presence of pharmaceutical dosage form additives. Spect Acta Mol Biomol Spect. 2016;160:50–7.

    Article  CAS  Google Scholar 

  26. Darwish HW, Hassan SA, Salem MY, El-Zeiny BA. Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of Amlodipine and Atorvastatin. Spect Acta Mol Biomol Spect. 2011;83(1):140–8.

    Article  CAS  Google Scholar 

  27. ICH. Q2B validation of analytical procedures: text and methodology. International Conference on Harmonization, Geneva, (2005).

  28. Rorabacher DB. Statistical treatment for rejection of deviant values: critical values of dixon’s" Q" parameter and related subrange ratios at the 95% confidence level. Anal Chem. 1991;63(2):139–46.

    Article  CAS  Google Scholar 

Download references


The authors express their gratitude to Mash Premiere Pharmaceutical Industries for donating us the pure modafinil sample.


Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This work wasn’t funded by any third party.

Author information

Authors and Affiliations



YF: planned, supervised the study and approved the final manuscript. SSEM: supervised analysis procedures, reviewing all results and the draft of manuscript. SE: carried out sample preparation, analysis, and writing the draft of manuscript. AMEH: supervision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sally S. El-Mosallamy.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elsheikh, S.G., El-Mosallamy, S.S., Fayez, Y.M. et al. Smart stability indicating spectrophotometric methods for determination of modafinil: the promising treatment for post-covid neurological syndrome. BMC Chemistry 16, 79 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: